BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31572518)

  • 1. miR-133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role.
    Yang Q; Zhao Q; Yin Y
    Exp Ther Med; 2019 Oct; 18(4):2711-2718. PubMed ID: 31572518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.
    Cao F; Liu Z; Sun G
    Exp Gerontol; 2020 Feb; 130():110814. PubMed ID: 31857133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Liu Q; Lei C
    Exp Gerontol; 2021 Feb; 144():111187. PubMed ID: 33279668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2.
    Wang R; Zhang J
    Exp Gerontol; 2020 Nov; 141():111080. PubMed ID: 32871216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-β induced neurotoxicity.
    Zhang H; Liu W; Ge H; Li K
    Neurosci Lett; 2021 Jun; 756():135953. PubMed ID: 33979697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
    Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation.
    Zhang M; Liu Y; Teng P; Yang Q
    Neuroimmunomodulation; 2022; 29(3):211-219. PubMed ID: 34749366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-149 is downregulated in Alzheimer's disease and inhibits β-amyloid accumulation and ameliorates neuronal viability through targeting BACE1.
    Du W; Lei C; Dong Y
    Genet Mol Biol; 2021; 44(1):e20200064. PubMed ID: 33428703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer's disease.
    Liu Y; Xu Y; Yu M
    Exp Ther Med; 2022 Mar; 23(3):241. PubMed ID: 35222718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
    Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
    BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease.
    Liu L; Liu L; Lu Y; Zhang T; Zhao W
    Biomark Med; 2021 Nov; 15(16):1499-1507. PubMed ID: 34668391
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
    Jia LH; Liu YN
    Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease.
    Ke S; Yang Z; Yang F; Wang X; Tan J; Liao B
    Yonsei Med J; 2019 Jul; 60(7):640-650. PubMed ID: 31250578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA SNHG1 attenuated Aβ
    Wang H; Lu B; Chen J
    Biochem Biophys Res Commun; 2019 Oct; 518(3):438-444. PubMed ID: 31447119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133b-5p Is Involved in Cardioprotection of Morphine Preconditioning in Rat Cardiomyocytes by Targeting Fas.
    He SF; Zhu HJ; Han ZY; Wu H; Jin SY; Irwin MG; Zhang Y
    Can J Cardiol; 2016 Aug; 32(8):996-1007. PubMed ID: 26919791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-149-5p inhibition reduces Alzheimer's disease β-amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8.
    Chen F; Chen H; Jia Y; Lu H; Tan Q; Zhou X
    Exp Ther Med; 2020 Nov; 20(5):88. PubMed ID: 32973937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced serum miR-202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein.
    Dong LH; Sun L; Zhang WJ; Wang XY; Li JM
    Kaohsiung J Med Sci; 2021 Aug; 37(8):730-738. PubMed ID: 34042273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.